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Figure 1 Effects of Dietary Nitrate Supplementation on Endothelial Function, Vascular Stiffness, and Blood Pressure
Dietary nitrate supplementation improved endothelial function as determined by ﬂow-mediated dilation (FMD), reduced vascular stiffness as assessed by augmentation index
(AIx@75bpm) and aortic pulse wave velocity (PWV), and lowered systolic blood pressure (SBP). Carotid intima-media thickness (IMT) and diastolic blood pressure (DBP)
remained unaffected. Values are presented as mean  SEM. *p < 0.05 (n ¼ 10 and n ¼ 11, respectively).
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of Patients With
Vasospastic AnginaI read with interest the report by Takagi et al (1). I was very
impressed by the amount of information they were able to gather
about a topic that is not frequently seen by any individual practi-
tioner. I congratulate the authors for trying to assess the risk of
vasospastic angina by developing a risk score.
I have 1 concern regarding the risk score: the history of out-of-
hospital cardiac arrest. Although I admit this is a risk for a future
event, it is also an endpoint for a major adverse cardiac event, and
I am not sure it belongs in the same category as smoking, angina at
rest, organic coronary stenosis, multivessel spasm, ST-segment
elevation during angina, and beta-blocker use.
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1586I alsonoticed that thedegreeof an acutemyocardial infarctiondidnot
seem to make any difference in terms of prognosis. Acute myocardial
infarction is also an endpoint for a major adverse cardiac event.
The only other issue I have with this well-written, interesting
article is that in the ﬁrst paragraph, the authors seem to equate
vasospastic angina with Prinzmetal angina or variant angina. I have
no doubt that the cause of the problem for the majority of patients
with Prinzmetal angina is coronary artery spasm, but not all
ST-segment elevation is related to the spasm. In fact, Prinzmetal
(2) described this syndrome before Mason Sones (3) wrote about
his experience with selective coronary angiography.
Another point that I think is useful to understand is that this is a
relatively recent experience with vasospastic angina, and thus these
patients were probably exposed to contemporary aggressive medical
management, including lipid reduction, blood pressure control, and
aspirin therapy.*C. Richard Conti, MD
*Division of Cardiovascular Medicine
Department of Medicine
University of Florida College of Medicine
P.O. Box 100277
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of Patients With
Vasospastic Angina
We thank Dr. Conti for his interest in our recent work (1). Indeed,
to the best of our knowledge, this is the ﬁrst risk score for vaso-
spastic angina (VSA), which is based on our experience with
1,429 patients registered with the Japanese Coronary Spasm As-
sociation (JCSA). We previously reported the prognostic signiﬁ-
cance of out-of-hospital cardiac arrest (OHCA) in our JCSA
registry study (2) and the clinical importance and safety of provo-
cation tests of coronary artery spasm (3).
First, Dr. Conti pointed out that a history of OHCA is an
endpoint for a major cardiac event in addition to a future event.Although we fully agree, we also would like to point out that a
substantial portion of patients with OHCA have survived with-
out neurological deﬁcits in the current era because of increasing use
of bystander cardiopulmonary resuscitation, use of implantable
cardioverter-deﬁbrillators, and hypothermia therapy and that a
higher portion of these patients are found to have coronary spasm,
at least in Japan (4). Thus, we included OHCA in our stratiﬁca-
tion analysis and found that it is indeed the most signiﬁcant
prognostic factor (1).
Second, Dr. Conti pointed out that we should be careful not to
confuse VSA with Prinzmetal angina or variant angina because
Prinzmetal described this syndrome before the development of
coronary angiography. Although we take this comment well, it is
generally accepted that Prinzmetal angina with ST-segment
elevation during angina at rest is caused by coronary spasm (but
not by nothing else) as a central form of VSA.
Third, Dr. Conti mentioned that the patients with VSA in the
JCSA registry were exposed to contemporary aggressive medical
management, including lipid reduction, blood pressure control,
and aspirin therapy. Indeed, this is the case. We would like to
emphasize that our novel risk score for VSA is useful for progno-
stic stratiﬁcation of not only Japanese patients, but also Western
patients, as we noted in a recent interview (5).*Hiroaki Shimokawa, MD, PhD
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